Roivant director granted 10,531 options, RSUs
Roivant Sciences director Daniel Allen Gold received new option and RSU awards that vest in 2027, increasing his directly held Common Shares to 8,965,815.
Rhea-AI Filing Summary
Roivant Sciences Ltd. (ROIV) reported that director Daniel Allen Gold received equity awards on September 16, 2026. He was granted 10,531 stock options to purchase Common Shares at an exercise price of $39.57 per share, expiring September 15, 2036, and an annual award of 5,054 RSUs, all vesting 100% on September 16, 2027, subject to continued board service. Following these grants, he directly holds 8,965,815 Common Shares. No Rule 10b5-1 trading plan is reported.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 15,585 shares
Grant/Award
2 txns
Insider
Gold Daniel Allen
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F2 | 10,531 | $0.00 | $0.00 |
| Grant/Award | Common Shares F1 | 5,054 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 10,531 contracts (Direct);
Common Shares — 8,965,815 shares (Direct)
Footnotes (2)
- F1. Reflects an annual award of restricted stock units with respect to Common Shares ("RSUs") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of RSUs is scheduled to vest 100% on September 16, 2027, subject generally to the reporting person's service as a director through such date.
- F2. Reflects an annual award of stock options to purchase Common Shares granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of stock options is scheduled to vest and become exercisable 100% on September 16, 2027, subject generally to the reporting person's service as a director through such date.
Key Figures
RSUs granted: 5,054 units
Stock options granted: 10,531 options
Option exercise price: $39.57 per share
+3 more
6 metrics
RSUs granted
5,054 units
Annual RSU award to director Daniel Allen Gold on September 16, 2026
Stock options granted
10,531 options
Annual option award to purchase Common Shares on September 16, 2026
Option exercise price
$39.57 per share
Exercise price of stock options granted to Daniel Allen Gold
Option expiration date
September 15, 2036
Expiration of the stock options granted on September 16, 2026
Common Shares held after transaction
8,965,815 shares
Direct ROIV Common Share holdings of Daniel Allen Gold following the grants
Vesting date for awards
September 16, 2027
Both RSUs and stock options vest 100% on this date, subject to service
Key Terms
restricted stock units, 2021 Equity Incentive Plan, Non-Employee Director Compensation Policy, stock options
4 terms
restricted stock units financial
"Reflects an annual award of restricted stock units with respect to Common Shares"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
2021 Equity Incentive Plan financial
"granted pursuant to the Company's 2021 Equity Incentive Plan"
Non-Employee Director Compensation Policy financial
"and the Company's Non-Employee Director Compensation Policy"
stock options financial
"Reflects an annual award of stock options to purchase Common Shares"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did ROIV grant to director Daniel Allen Gold on September 16, 2026?
On September 16, 2026, Daniel Allen Gold received 10,531 stock options with an exercise price of $39.57 per share and an annual grant of 5,054 restricted stock units (RSUs), all under Roivant Sciences’ 2021 Equity Incentive Plan and Non-Employee Director Compensation Policy.
When do Daniel Allen Gold’s new ROIV RSUs and options vest?
Both the 5,054 RSUs and the 10,531 stock options are scheduled to vest and become 100% vested or exercisable on September 16, 2027, subject generally to Daniel Allen Gold’s continued service as a director through that date.
What is the exercise price and expiration date of Daniel Allen Gold’s new ROIV stock options?
The new stock options granted to Daniel Allen Gold have an exercise price of $39.57 per Common Share and are scheduled to expire on September 15, 2036, if not earlier exercised or forfeited under their terms.
Were Daniel Allen Gold’s ROIV transactions made under a Rule 10b5-1 trading plan?
No. The Form 4 indicates the Rule 10b5-1 checkbox is not marked, and the footnotes describe the awards as annual grants under Roivant Sciences’ 2021 Equity Incentive Plan and Non-Employee Director Compensation Policy, not pursuant to a Rule 10b5-1 plan.
Are Daniel Allen Gold’s new ROIV awards market purchases or compensation grants?
They are compensation grants, not market purchases. The filings describe them as an annual award of RSUs and an annual award of stock options granted pursuant to Roivant Sciences’ 2021 Equity Incentive Plan and its Non-Employee Director Compensation Policy, with a reported price per share of $0.00.
AI-generated analysis. How Rhea-AI works. Not financial advice.
